ArticleInflammopharmacology2024

PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.

Anderson Rodrigues de Almeida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.